ProKidney Reports Full Year 2024 Financial Results and Business Highlights
Provided By GlobeNewswire
Last update: Mar 17, 2025
WINSTON-SALEM, N.C., March 17, 2025 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney”), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced financial results and business highlights for the year ended December 31, 2024.
Read more at globenewswire.com0.6601
-0.04 (-5.2%)
Find more stocks in the Stock Screener
PROK Latest News and Analysis
2 days ago - ChartmillWhat's going on in today's after hours sessionDiscover the top movers in Friday's after-hours session and stay informed about the post-market dynamics.
